DE60332534D1 - Chinuclidinamidderivate - Google Patents

Chinuclidinamidderivate

Info

Publication number: DE60332534D1
Authority: DE; Germany
Prior art keywords: chinuclidinamidderivate
Prior art date: 2002-07-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE60332534T

Other languages

English (en)

Inventor

Quinones Maria Prat

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Almirall SA

Original Assignee

Almirall SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-02

Filing date

2003-06-25

Publication date

2010-06-24

2003-06-25 Application filed by Almirall SA filed Critical Almirall SA

2010-06-24 Application granted granted Critical

2010-06-24 Publication of DE60332534D1 publication Critical patent/DE60332534D1/de

2023-06-26 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DE60332534T 2002-07-02 2003-06-25 Chinuclidinamidderivate Expired - Fee Related DE60332534D1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ES200201539A ES2204295B1 (es)	2002-07-02	2002-07-02	Nuevos derivados de quinuclidina-amida.
PCT/EP2003/006708 WO2004005285A1 (en)	2002-07-02	2003-06-25	New quinuclidine amide derivatives

Publications (1)

Publication Number	Publication Date
DE60332534D1 true DE60332534D1 (de)	2010-06-24

Family

ID=30011350

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60332534T Expired - Fee Related DE60332534D1 (de)	2002-07-02	2003-06-25	Chinuclidinamidderivate

Country Status (24)

Country	Link
US (2)	US7488735B2 (de)
EP (1)	EP1519933B1 (de)
JP (1)	JP2005533826A (de)
CN (1)	CN100404533C (de)
AR (1)	AR040351A1 (de)
AT (1)	ATE467631T1 (de)
AU (1)	AU2003242757B2 (de)
BR (1)	BR0312216A (de)
CA (1)	CA2492535A1 (de)
DE (1)	DE60332534D1 (de)
EC (1)	ECSP045519A (de)
ES (1)	ES2204295B1 (de)
IL (1)	IL165923A (de)
MX (1)	MXPA04012271A (de)
MY (1)	MY130803A (de)
NO (1)	NO20050164L (de)
NZ (1)	NZ537341A (de)
PE (1)	PE20040644A1 (de)
RU (1)	RU2314306C2 (de)
TW (1)	TW200402420A (de)
UA (1)	UA80832C2 (de)
UY (1)	UY27870A1 (de)
WO (1)	WO2004005285A1 (de)
ZA (1)	ZA200410404B (de)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2165768B1 (es)	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
KR100869722B1 (ko)	2000-12-22	2008-11-21	알미랄 에이쥐	퀴누클리딘 카르바메이트 유도체 및 ｍ3 길항제로서 그의사용
ES2203327B1 (es)	2002-06-21	2005-06-16	Almirall Prodesfarma, S.A.	Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
TW200519106A (en)	2003-05-02	2005-06-16	Novartis Ag	Organic compounds
GB0401334D0 (en)	2004-01-21	2004-02-25	Novartis Ag	Organic compounds
ES2239546B1 (es) *	2004-03-15	2006-12-01	Almirall Prodesfarma, S.A.	Nuevos esteres de quinuclidina cuaternizados.
PE20060259A1 (es) *	2004-04-27	2006-03-25	Glaxo Group Ltd	Compuestos de quinuclidina como antagonistas del receptor de acetilcolina muscarinico
US7598267B2 (en) *	2004-05-13	2009-10-06	Glaxo Group Limited	Muscarinic acetylcholine receptor antagonists
GB0411056D0 (en)	2004-05-18	2004-06-23	Novartis Ag	Organic compounds
ES2246170B1 (es) *	2004-07-29	2007-04-01	Almirall Prodesfarma, S.A.	Nuevo procedimiento para preparar derivados de carbamato de quinuclidinio.
JP4781362B2 (ja) *	2004-09-15	2011-09-28	書強趙	４級アンモニウム基を有するキヌクリジン化合物とその調製方法、およびアセチルコリン遮断剤としての用途
GT200500281A (es)	2004-10-22	2006-04-24	Novartis Ag	Compuestos organicos.
GB0426164D0 (en)	2004-11-29	2004-12-29	Novartis Ag	Organic compounds
GB0507577D0 (en)	2005-04-14	2005-05-18	Novartis Ag	Organic compounds
GB0510390D0 (en)	2005-05-20	2005-06-29	Novartis Ag	Organic compounds
MY144906A (en)	2005-10-21	2011-11-30	Novartis Ag	Human antibodies against il13 and therapeutic uses
US9088384B2 (en) *	2005-10-27	2015-07-21	Qualcomm Incorporated	Pilot symbol transmission in wireless communication systems
GB0601951D0 (en)	2006-01-31	2006-03-15	Novartis Ag	Organic compounds
AR060607A1 (es)	2006-04-21	2008-07-02	Novartis Ag	Derivados de purina,composiciones farmaceuticas que los contienen, metodo de preparacion y usos en enfermedades obstructivas o inflamatorias de las vias respiratorias.
ES2298049B1 (es) *	2006-07-21	2009-10-20	Laboratorios Almirall S.A.	Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
BRPI0717564A2 (pt)	2006-09-29	2013-10-22	Novartis Ag	Pirazolopirimidinas como inibidores de pi3k lipídeo cinase
US20080176901A1 (en)	2007-01-10	2008-07-24	Irm Llc	Compounds and compositions as channel activating protease inhibitors
KR101495708B1 (ko) *	2007-02-23	2015-02-25	세라밴스 바이오파마 알앤디 아이피, 엘엘씨	무스카린 수용체 안타고니스트로 유용한 4차 암모늄 디페닐메틸 화합물
AU2008248598B2 (en)	2007-05-07	2011-11-17	Novartis Ag	Organic compounds
ES2654395T3 (es)	2007-12-10	2018-02-13	Novartis Ag	Análogos de amilorida espirocíclicos como bloqueantes de ENaC
JP5584138B2 (ja)	2008-01-11	2014-09-03	ノバルティスアーゲー	キナーゼ阻害剤としてのピリミジン類
WO2009098453A1 (en) *	2008-02-06	2009-08-13	Astrazeneca Ab	Azonia bicycloalkanes as m3 muscarinic acetylcholin receptor antagonists
WO2009098455A1 (en) *	2008-02-06	2009-08-13	Astrazeneca Ab	2- (9h-xanthen-9-yl) -oxazol derivatives as m3 muscarinic receptor antagonists for the treatment of asthma and chronic obstructive lung disease
EP2100598A1 (de)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2100599A1 (de)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
US8268834B2 (en)	2008-03-19	2012-09-18	Novartis Ag	Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
EP2300010B1 (de)	2008-06-10	2015-03-04	Novartis AG	Pyrazinderivate als blockierer des epithelialen natriumkanals
GB0814729D0 (en) *	2008-08-12	2008-09-17	Argenta Discovery Ltd	New combination
GB0814728D0 (en) *	2008-08-12	2008-09-17	Argenta Discovery Ltd	New combination
CA2733449A1 (en) *	2008-08-12	2010-02-18	Astrazeneca Ab	2-hydroxy-ethanesulfonate salt
DK2391366T3 (da)	2009-01-29	2013-01-07	Novartis Ag	Substituerede benzimidazoler til behandling af astrocytomer
US8389526B2 (en)	2009-08-07	2013-03-05	Novartis Ag	3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
JP5781510B2 (ja)	2009-08-12	2015-09-24	ノバルティスアーゲー	ヘテロ環式ヒドラゾン化合物および癌および炎症の処置のためのそれらの使用
HRP20190016T1 (hr)	2009-08-17	2019-03-08	Intellikine, Llc	Heterociklički spojevi i njihova upotreba
MX2012002179A (es)	2009-08-20	2012-03-16	Novartis Ag	Compuestos heterociclicos de oxima.
MX2012004792A (es)	2009-10-22	2013-02-01	Vertex Pharma	Composiciones para el tratamiento de fibrosis quistica y otras enfermedades cronicas.
US8247436B2 (en)	2010-03-19	2012-08-21	Novartis Ag	Pyridine and pyrazine derivative for the treatment of CF
WO2012034095A1 (en)	2010-09-09	2012-03-15	Irm Llc	Compounds and compositions as trk inhibitors
UY33597A (es)	2010-09-09	2012-04-30	Irm Llc	Compuestos y composiciones como inhibidores de la trk
US8372845B2 (en)	2010-09-17	2013-02-12	Novartis Ag	Pyrazine derivatives as enac blockers
US20130324526A1 (en)	2011-02-10	2013-12-05	Novartis Ag	[1,2,4] triazolo [4,3-b] pyridazine compounds as inhibitors of the c-met tyrosine kinase
JP5808826B2 (ja)	2011-02-23	2015-11-10	インテリカイン，エルエルシー	複素環化合物およびその使用
JP5959541B2 (ja)	2011-02-25	2016-08-02	ノバルティスアーゲー	Ｔｒｋ阻害剤としてのピラゾロ［１，５−ａ］ピリジン
EP2510928A1 (de)	2011-04-15	2012-10-17	Almirall, S.A.	Aclidinium zur Verbesserung der Schlafqualität bei atemwegserkrankten Patienten
WO2012146515A1 (en) *	2011-04-29	2012-11-01	Chiesi Farmaceutici S.P.A.	Alkaloid ester and carbamate derivatives and medicinal compositions thereof
UY34305A (es)	2011-09-01	2013-04-30	Novartis Ag	Derivados de heterociclos bicíclicos para el tratamiento de la hipertensión arterial pulmonar
WO2013038362A1 (en)	2011-09-15	2013-03-21	Novartis Ag	6 - substituted 3 - (quinolin- 6 - ylthio) - [1,2,4] triazolo [4, 3 -a] pyradines as tyrosine kinase
WO2013038373A1 (en)	2011-09-16	2013-03-21	Novartis Ag	Pyridine amide derivatives
ES2882807T3 (es)	2011-09-16	2021-12-02	Novartis Ag	Heterociclil carboxamidas N-sustituidas
US9034879B2 (en)	2011-09-16	2015-05-19	Novartis Ag	Heterocyclic compounds for the treatment of CF
WO2013038378A1 (en)	2011-09-16	2013-03-21	Novartis Ag	Pyridine amide derivatives
WO2013038381A1 (en)	2011-09-16	2013-03-21	Novartis Ag	Pyridine/pyrazine amide derivatives
JP6130391B2 (ja)	2011-11-23	2017-05-17	インテリカイン，エルエルシー	Ｍｔｏｒ阻害剤を使用する強化された治療レジメン
US8809340B2 (en)	2012-03-19	2014-08-19	Novartis Ag	Crystalline form
WO2013149581A1 (en)	2012-04-03	2013-10-10	Novartis Ag	Combination products with tyrosine kinase inhibitors and their use
US9073921B2 (en)	2013-03-01	2015-07-07	Novartis Ag	Salt forms of bicyclic heterocyclic derivatives
HK1219421A1 (zh)	2013-03-15	2017-04-07	因特利凯有限责任公司	激酶抑制剂的组合及其用途
EP3023424B1 (de) *	2013-07-13	2019-02-27	Beijing Shuobai Pharmaceutical Co., Ltd.	Chininverbindungen und optische isomere, herstellungsverfahren und medizinische verwendung davon
TW201605450A (zh)	2013-12-03	2016-02-16	諾華公司	Ｍｄｍ２抑制劑與ＢＲＡＦ抑制劑之組合及其用途
EA201692140A1 (ru)	2014-04-24	2017-04-28	Новартис Аг	Производные аминопиридина в качестве ингибиторов фосфатидилинозитол 3-киназы
WO2015162461A1 (en)	2014-04-24	2015-10-29	Novartis Ag	Pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
MX2016013812A (es)	2014-04-24	2017-03-09	Novartis Ag	Derivados de amino-pirazina como inhibidores de fosfatidil-inositol-3-cinasa.
JP6836502B2 (ja) *	2014-05-30	2021-03-03	スプハエラファーマピーヴィーティーリミテッド	抗結核薬としての新規な化合物
WO2016011658A1 (en)	2014-07-25	2016-01-28	Novartis Ag	Combination therapy
BR112017001695A2 (pt)	2014-07-31	2017-11-21	Novartis Ag	terapia de combinação
JP2022537667A (ja)	2019-06-10	2022-08-29	ノバルティスアーゲー	Ｃｆ、ｃｏｐｄ、及び気管支拡張症の治療のためのピリジン及びピラジン誘導体
EP4021572A1 (de)	2019-08-28	2022-07-06	Novartis AG	Substituierte 1,3-phenylheteroarylderivate und ihre verwendung zur behandlung von krankheiten
CN110759904B (zh) *	2019-10-21	2023-03-14	河南科技大学	9r-酰氧基奎宁类衍生物及其制备方法、奎宁或其衍生物的应用、植物源杀虫剂
TW202140550A (zh)	2020-01-29	2021-11-01	瑞士商諾華公司	使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2762796A (en)		1956-09-11		Iminodibenzyl derivative
GB1219606A (en) *	1968-07-15	1971-01-20	Rech S Et D Applic Scient Soge	Quinuclidinol derivatives and preparation thereof
GB1246606A (en)	1969-04-28	1971-09-15	Starogardzkie Zakl Farma	Dibenzo-azepine derivatives
IL72788A (en)	1984-08-28	1989-07-31	Israel State	Bis quaternary oxy-bis methylene(or trimethylene)bis-n-quinuclidines,pyridines and piperidines,their preparation and antidotes against organophosphorus and carbamate poisoning containing them
GB2225574B (en)	1987-12-24	1991-04-24	Wyeth John & Brother Ltd	Heterocyclic compounds
GB8825505D0 (en) *	1988-11-01	1988-12-07	Pfizer Ltd	Therapeutic agents
GB8923590D0 (en)	1989-10-19	1989-12-06	Pfizer Ltd	Antimuscarinic bronchodilators
GB9201751D0 (en)	1992-01-28	1992-03-11	Smithkline Beecham Plc	Compounds
GB9202443D0 (en) *	1992-02-05	1992-03-18	Fujisawa Pharmaceutical Co	A novel substituted-acetamide compound and a process for the preparation thereof
AU7545894A (en) *	1993-09-02	1995-03-22	Yamanouchi Pharmaceutical Co., Ltd.	Carbamate derivative and medicine containing the same
EP0747355A4 (de)	1994-02-10	1997-04-09	Yamanouchi Pharma Co Ltd	Neue carbamate und diese enthaltende arzneimittel
NO2005012I1 (no) *	1994-12-28	2005-06-06	Debio Rech Pharma Sa	Triptorelin og farmasoytisk akseptable salter derav
WO1997013766A1 (en) *	1995-10-13	1997-04-17	Banyu Pharmaceutical Co., Ltd.	Substituted heteroaromatic derivatives
AUPN862996A0 (en)	1996-03-13	1996-04-04	Fujisawa Pharmaceutical Co., Ltd.	A novel substituted-acetamide compound
PE92198A1 (es) *	1996-08-01	1999-01-09	Banyu Pharma Co Ltd	Derivados de 1,4-piperidina disustituida que contienen fluor
ES2165768B1 (es) *	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
EA005520B1 (ru)	2000-06-27	2005-04-28	Лабораториос С.А.Л.В.А.Т.,С.А.	Карбаматы, полученные из арилалкиламинов
KR100869722B1 (ko)	2000-12-22	2008-11-21	알미랄 에이쥐	퀴누클리딘 카르바메이트 유도체 및 ｍ3 길항제로서 그의사용
NZ526674A (en) *	2000-12-28	2005-03-24	Almirall Prodesfarma Ag	Novel quinuclidine derivatives and medicinal compositions containing the same
RS52522B (sr)	2001-12-20	2013-04-30	Chiesi Farmaceutici S.P.A.	Derivati 1-alkil-1-azoniabiciklo/2.2.2./oktan karbamata i njihova upotreba kao antagonista muskarinskih receptora
ES2203327B1 (es)	2002-06-21	2005-06-16	Almirall Prodesfarma, S.A.	Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
CA2499639C (en)	2002-09-19	2011-11-08	Schering Corporation	Imidazopyridines as cyclin dependent kinase inhibitors

2002
- 2002-07-02 ES ES200201539A patent/ES2204295B1/es not_active Expired - Fee Related
2003
- 2003-06-25 AU AU2003242757A patent/AU2003242757B2/en not_active Ceased
- 2003-06-25 RU RU2005102585/04A patent/RU2314306C2/ru not_active IP Right Cessation
- 2003-06-25 DE DE60332534T patent/DE60332534D1/de not_active Expired - Fee Related
- 2003-06-25 BR BR0312216-6A patent/BR0312216A/pt not_active IP Right Cessation
- 2003-06-25 EP EP03762514A patent/EP1519933B1/de not_active Expired - Lifetime
- 2003-06-25 MX MXPA04012271A patent/MXPA04012271A/es active IP Right Grant
- 2003-06-25 AT AT03762514T patent/ATE467631T1/de not_active IP Right Cessation
- 2003-06-25 CN CNB03820648XA patent/CN100404533C/zh not_active Expired - Fee Related
- 2003-06-25 NZ NZ537341A patent/NZ537341A/xx unknown
- 2003-06-25 WO PCT/EP2003/006708 patent/WO2004005285A1/en not_active Ceased
- 2003-06-25 JP JP2004518575A patent/JP2005533826A/ja active Pending
- 2003-06-25 CA CA002492535A patent/CA2492535A1/en not_active Abandoned
- 2003-06-25 UA UAA200500839A patent/UA80832C2/uk unknown
- 2003-06-25 US US10/518,714 patent/US7488735B2/en not_active Expired - Fee Related
- 2003-06-27 UY UY27870A patent/UY27870A1/es not_active Application Discontinuation
- 2003-06-30 MY MYPI20032447A patent/MY130803A/en unknown
- 2003-06-30 PE PE2003000662A patent/PE20040644A1/es not_active Application Discontinuation
- 2003-06-30 AR ARP030102368A patent/AR040351A1/es unknown
- 2003-07-02 TW TW092118081A patent/TW200402420A/zh unknown
2004
- 2004-12-22 IL IL165923A patent/IL165923A/en not_active IP Right Cessation
- 2004-12-23 ZA ZA200410404A patent/ZA200410404B/xx unknown
- 2004-12-29 EC EC2004005519A patent/ECSP045519A/es unknown
2005
- 2005-01-12 NO NO20050164A patent/NO20050164L/no not_active Application Discontinuation
2008
- 2008-01-08 US US11/970,698 patent/US7718670B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CN100404533C (zh)	2008-07-23
US20080234316A1 (en)	2008-09-25
RU2005102585A (ru)	2005-10-10
BR0312216A (pt)	2005-04-12
MY130803A (en)	2007-07-31
ATE467631T1 (de)	2010-05-15
NO20050164L (no)	2005-04-04
ES2204295B1 (es)	2005-08-01
US7488735B2 (en)	2009-02-10
CN1678610A (zh)	2005-10-05
ES2204295A1 (es)	2004-04-16
ECSP045519A (es)	2005-03-10
RU2314306C2 (ru)	2008-01-10
AU2003242757B2 (en)	2009-01-08
WO2004005285A1 (en)	2004-01-15
PE20040644A1 (es)	2004-09-18
UA80832C2 (en)	2007-11-12
AU2003242757A1 (en)	2004-01-23
MXPA04012271A (es)	2005-04-08
CA2492535A1 (en)	2004-01-15
ZA200410404B (en)	2005-09-05
JP2005533826A (ja)	2005-11-10
UY27870A1 (es)	2003-10-31
EP1519933B1 (de)	2010-05-12
NZ537341A (en)	2006-04-28
IL165923A (en)	2010-06-30
US7718670B2 (en)	2010-05-18
EP1519933A1 (de)	2005-04-06
AR040351A1 (es)	2005-03-30
US20060167042A1 (en)	2006-07-27
TW200402420A (en)	2004-02-16
IL165923A0 (en)	2006-01-15

Publication	Publication Date	Title
DE50313647D1 (de)	2011-06-01	Knochenfixationseinrichtumg
DE60332534D1 (de)	2010-06-24	Chinuclidinamidderivate
ATE457980T1 (de)	2010-03-15	Aryloxime
ATE534648T1 (de)	2011-12-15	C-6-modifizierte indazolylpyrrolotriazine
DE50305852D1 (de)	2007-01-11	Einspritzventil
DE50306589D1 (de)	2007-04-05	Wischblatt
DE50310083D1 (de)	2008-08-14	Phthalocyaninpigmentzubereitungen
ATE427876T1 (de)	2009-04-15	Luftkissenboot
DE50212349D1 (de)	2008-07-17	Hirurgie
DE50301200D1 (de)	2005-10-20	Wischblatt
DE50311715D1 (de)	2009-08-27	Weltzeituhr
DE50305301D1 (de)	2006-11-16	Einspritzventil
DE50309536D1 (de)	2008-05-15	Fadenabsaugvorrichtung
ATA1572002A (de)	2003-06-15	Managementspleisskassette
DE50302660D1 (de)	2006-05-11	Stopfmachine
DE50307971D1 (de)	2007-09-27	Gelenklager
DE50301960D1 (de)	2006-01-26	Hydrolager
DE50301464D1 (de)	2005-12-01	Schraubensicherung
DE50312275D1 (de)	2010-02-04	Trägerverbau
ATE469773T1 (de)	2010-06-15	Zugöse
DE50305973D1 (de)	2007-01-25	Auffangwanne
DE50303317D1 (de)	2006-06-14	Einschub-leistungsschalter
ATA19152002A (de)	2004-11-15	Hubkupplung
DE50308979D1 (de)	2008-02-21	Einspritzventil
DE50209283D1 (de)	2007-03-08	Tropfbewässerungsrohr

Legal Events

Date	Code	Title	Description
2011-04-21	8339	Ceased/non-payment of the annual fee